midazolam
Phase 3- Indications
- Epilepsy
Company intelligence / Profile preview
Intranasal Therapeutics, Inc.
Saddle Brook, New Jersey, United Statesbiospace.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Intranasal Therapeutics developed nasally delivered, preservative-free pharmaceuticals targeting pain and CNS disorders. Its lead programs included intranasal hydromorphone for acute pain and midazolam/lorazepam sprays for seizure control. The company completed at least eighteen human trials involving over three hundred subjects by the time it closed its $39M Series A round. In early clinical results, their formulations aimed to improve patient comfort by eliminating preservatives while maintaining efficacy.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesNasally delivered drug products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharma partnerships publicly disclosed; technology licensed from University of Kentucky.
Beyond the preview
Go deeper on Intranasal Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intranasal Therapeutics, Inc..